Promoter hypermethylation of SFRP1 as a prognostic and potentially predictive blood-based biomarker in patients with stage III or IV pancreatic ductal adenocarcinoma

Autor: Benjamin E. Stubbe, Poul H. Madsen, Anders C. Larsen, Henrik B. Krarup, Inge S. Pedersen, Carsten P. Hansen, Julia S. Johansen, Stine D. Henriksen, Ole Thorlacius-Ussing

Publikováno v: Stubbe, B 2023, ' Promoter hypermethylation of SFRP1 as a prognostic and potentially predictive blood-based biomarker in patients with stage III or IV pancreatic ductal adenocarcinoma ', Pancreatology . https://doi.org/10.1016/j.pan.2023.05.003
Stubbe, B, Madsen, P H, Larsen, A C, Krarup, H B, Pedersen, I S, Johansen, J S, Henriksen, S D & Thorlacius-Ussing, O 2023, ' Promoter hypermethylation of SFRP1 as a prognostic and potentially predictive blood-based biomarker in patients with stage III or IV pancreatic ductal adenocarcinoma ', Pancreatology . https://doi.org/10.1016/j.pan.2023.05.003

BackgroundPancreatic ductal adenocarcinoma remains one of the major causes of cancer-related mortality globally. Unfortunately, current prognostic biomarkers are limited, and no predictive biomarkers exist. This study examined promoter hypermethylati

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::de3cee6e3a023423872c6cc41de9e45c
https://vbn.aau.dk/da/publications/a5db5b62-6897-44f8-b46c-67413b030d2c

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Abstract B047: Promoter hypermethylation of SFRP1 as a prognostic and predictive blood-based biomarker in patients with stage IV pancreatic ductal adenocarcinoma

Autor: Benjamin E. Stubbe, Stine D. Henriksen, Poul H. Madsen, Anders C. Larsen, Henrik B. Krarup, Inge S. Pedersen, Julia S. Johansen, Carsten P. Hansen, Ole Thorlacius-Ussing

Publikováno v: Cancer Research. 82:B047-B047

Background: Pancreatic ductal adenocarcinoma (PDAC) is a disease with an abysmal prognosis. Unfortunately, no reliable prognostic or predictive blood-based biomarkers are currently available. An increasingly promising prognostic and predictive tool i

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::49d6e15658c83466de859ab188481772
https://doi.org/10.1158/1538-7445.panca22-b047

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Co-Imagining the Futures of Implementation Precision Medicine Using Scenario Analysis and Design Fiction

Autor: Riley Pates, Karla Vargas, Nolan Harrington, Noah Etka, Meghan Jennings, Emily York, Anne D Henriksen, Samuel Kodua, Dorothy Caserta, Zachary Sevison, Shannon N. Conley, Elizabeth Terry, Sydney VanNostrand

Publikováno v: OMICS: A Journal of Integrative Biology. 23:340-349

Precision medicine has a long history dating to the early 20th century when inquiries into the biochemical basis of large person-to-person variations in susceptibility to human diseases and response to medicines had first begun. Yet, personalized med

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e7c3163b422d2774ab13c9c092ee3e51
https://doi.org/10.1089/omi.2019.0083